camptothecin has been researched along with nateglinide in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Itagaki, S | 1 |
1 review(s) available for camptothecin and nateglinide
| Article | Year |
|---|---|
[Intestinal absorption and secretion mechanism of carboxylate drugs].
Topics: Administration, Oral; Angiotensin-Converting Enzyme Inhibitors; Antineoplastic Agents, Phytogenic; Benzimidazoles; Benzoates; Camptothecin; Coumaric Acids; Cyclohexanes; Drug Interactions; Flavonoids; Food-Drug Interactions; Functional Food; Humans; Hypoglycemic Agents; Intestinal Absorption; Irinotecan; Monocarboxylic Acid Transporters; Nateglinide; Phenols; Phenylalanine; Polyphenols; Telmisartan | 2009 |
1 other study(ies) available for camptothecin and nateglinide
| Article | Year |
|---|---|
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |